Explore evidence

1.7 per_100_person_yearsIn patients with pre-ART CD4 cell count 200–349 cells/μL, incidence of mortality was 1.7 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2007AIDS (London, England)europe_pmcdocument of 9 observations

85.7 %Of the 312 patients initially classified as HIV-2, 267 (85.7%) were confirmed as HIV-2.

Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations

100,000 copies/mLBaseline HIV-1 RNA <100 000 copies/mL was associated with virologic success.

Côte d'IvoireVIH/sidaobserved baselinepublished 2022Open Forum Infectious Diseaseseurope_pmcdocument of 4 observationsDOI 10.1093/ofid/ofac628

30 deathsIn the Temprano ANRS 12136 trial posttrial phase, 30 deaths occurred among HIV-infected West African adults who were randomized to defer antiretroviral therapy.

Côte d'IvoireVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 6 observations

4 %The Senegal haplotype was detected in 4% of samples.

Côte d'Ivoirehemoglobinobserved 2022HAL · Unilimdocument of 23 observations

5.2 per_100_person_yearsAmong 1825 HIV-2-infected individuals initiating antiretroviral therapy, the mortality rate was 5.2 per 100 person-years of observation over the first 24 months.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

4.7 log10 copies/mlThe median pre-antiretroviral treatment HIV-1 RNA level was 4.7 log10 copies per milliliter among 1013 patients in the Temprano trial conducted in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublished 2022BMC infectious diseaseseurope_pmcdocument of 3 observationsDOI 10.1186/s12879-022-07082-2

0 %Plasmodium malariae accounted for 0.00% of identified Plasmodium species among 2246 positive blood smears.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

73.33 %La fréquence de la neuropathie sensitive, sensitivo-motrice, polyneuropathique, démyélinisante, axonale et axono-démyélinisante chez les personnes diabétiques en Côte d'Ivoire était de 73,33 % en 2004.

Côte d'Ivoirediabète (non précisé) · neuropathie axonale · neuropathie axono-démyélinisante · neuropathie démyélinisante · neuropathie périphériqueobserved 2004HAL · Unilimdocument of 747 observations

34.3 %A seropositivity to HIV1 and/or HIV2 was observed in 72 (34.3%) of 210 female prostitutes in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations

351 individualsA total of 351 HIV-2-infected individuals participated in this study.

Côte d'IvoireVIH/sidaobserved 2012published 2015PloS oneeurope_pmcdocument of 9 observations

35.3 %A seropositivity to HIV1 and/or HIV2 was observed in 23 (35.3%) of 65 patients with sexual transmitted diseases in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations

Symptomatic malaria case prevalence was the highest in Karafine (KAR).

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

19.3 %After 24 months of follow-up, 6 out of 31 patients (19.3%) died.

Côte d'Ivoireméningite cryptococciquepublished 2025IJID regionseurope_pmcdocument of 11 observations

4.5 per_100_person-yearsHIV incidence among regular male blood donors in Abidjan decreased from 4.5 per 100 person-years in 1992–1994 to 0.06 per 100 person-years in 2010–2012.

Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations

9.1 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 9.1% for those attending HIV care facilities located in Abidjan and 20.4% for those attending facilities outside Abidjan in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations

32.2 %Of 457 participants included in this study, 147 (32.2%) had a positive urinary LAM.

Côte d'Ivoiretuberculosepublished 2025BMC infectious diseaseseurope_pmcdocument of 9 observations

4.3 %HCV prevalence was 4.3% among HIV-1-infected patients in the IeDEA HIV-2 West Africa cohort surveyed from March to December 2012.

Côte d'Ivoirehépatite C · VIH/sidaobserved March to December 2012published 2018Journal of public health in Africaeurope_pmcdocument of 9 observations

10.8 %Among individuals aged 13–21 years and older, malaria prevalence was 10.8%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

The highest malaria case rates were recorded at the end of the rainy season (November–December 2016).

Côte d'Ivoirepaludismeobserved November–December 2016HAL · Unilimdocument of 122 observations

14.7 %Among 659 AGLHIV in Côte d'Ivoire participating in the COVADOCI study, 97 (14.7%) had received at least one HPV vaccine dose.

Côte d'Ivoireinfection à HPVHAL · Unilimdocument of 69 observations

The treatment has been unsuccessful.

Côte d'Ivoirevisceral leishmaniasispublished 2008Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 4 observations

21.3 %Occult HBV infection prevalence was 21.3% among HBsAg-negative, anti-HBcAb-positive, anti-HBsAb-negative patients with detectable HBV DNA.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

5.2 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of miscarriage was 5.2%.

Côte d'IvoireVIH/sidaobserved 2003–2009published 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

24.6 %Of 422 HIV-2-infected patients, 104 (24.6%) were treated with an unboosted PI-based regimen.

Côte d'IvoireVIH/sidapublished 2016Journal of the International AIDS Societyeurope_pmcdocument of 6 observations